Evidence map›Paper›PMID 29976671›Full record

ArticleJournal of virology2018

CD32

Alessandra Noto, Francesco A Procopio, Riddhima Banga, Madeleine Suffiotti, Jean-Marc Corpataux, Matthias Cavassini, Agostino Riva, Craig Fenwick, Raphael Gottardo, Matthieu Perreau and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 40 citations in OpenAlex.

  1. Targeting PD-1Science advances · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Ocrelizumab Impairs the Phenotype and Function of Memory CD8Neurology(R) neuroimmunology & neuroinflammation · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. CD32iScience · 2021
    Article
  13. Review
  14. Review
  15. CD32Frontiers in immunology · 2021
    Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

Alessandra NotoService of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.ORCID https://orcid.org/0000-0003-2813-9488
Francesco A ProcopioService of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Riddhima BangaService of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Madeleine SuffiottiService of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Jean-Marc CorpatauxService of Vascular Surgery, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Matthias CavassiniService of Infectious Diseases, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Agostino RivaInfectious Disease Division, Luigi Sacco University Hospital, Milan, Italy.
Craig FenwickService of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Raphael GottardoVaccine Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Matthieu PerreauService of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
Giuseppe PantaleoService of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland Giuseppe.Pantaleo@chuv.ch.
University of Lausanne · CHFred Hutch Cancer Center · USLuigi Sacco Hospital · ITSwiss Vaccine Research Institute · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A recent study conducted in blood has proposed CD32 as the marker identifying the "elusive" HIV reservoir. We have investigated the distribution of CD32

Indexed as

Transcription, GeneticAdultAnti-Retroviral AgentsCD4-Positive T-LymphocytesDNA, ViralFemaleHIV-1HIV InfectionsHumansLymph NodesMaleMiddle AgedProgrammed Cell Death 1 ReceptorReceptors, IgGRNA, ViralT-Lymphocyte SubsetsAnti-Retroviral AgentsDNA, ViralPDCD1 protein, humanProgrammed Cell Death 1 ReceptorReceptors, IgGRNA, ViralCD32human immunodeficiency viruslymph nodePD-1Tfh cells

Identifiers

PMID29976671
PMCPMC6158413
OpenAlexW2949194343

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.